The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review
Open Access
- 11 September 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 2073
Abstract
Cardiogenic shock (CS) is one of the most serious complications of myocardial infarction (MI) with a high mortality rate. The timely and effective prevention and early suppression of this adverse event may influence the prognosis and outcome in patients with MI complicated by CS (MI CS). Despite the use of existing pharmaco-invasive options for maintaining an optimal pumping function of the heart in patients with MI CS, its mortality remains high, prompting the search for new approaches to pathogenetic therapy. This review considers the role of the systemic inflammatory response in the pathogenesis of MI CS. The primary processes involved in its initiation are described, including the progression from the onset of MI to the generalization of the inflammatory response and the development of multiple organ dysfunction. The approaches to anti-inflammatory therapy in patients with CS are discussed, and further promising research directions are outlined. In this review, we updated and summarized information on the inflammatory component of MI CS pathogenesis with a particular focus on its foundational aspects. This will facilitate the identification of specific inflammatory phenotypes and endotypes in MI CS and the development of targeted therapeutic strategies for this MI complication.Keywords
Funding Information
- Laboratory of Myocardial Infarction-Associated Shock (075-00712-24-04)
This publication has 101 references indexed in Scilit:
- Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shockEuropean Journal of Heart Failure, 2022
- Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial InfarctionJAMA Network Open, 2020
- Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves HaemodynamicsEuropean Journal of Heart Failure, 2019
- SCAI clinical expert consensus statement on the classification of cardiogenic shockCatheterization and Cardiovascular Interventions, 2019
- Growth-Differentiation Factor 15 and Osteoprotegerin in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Biomarker Substudy of the IABP-SHOCK II-TrialEuropean Journal of Heart Failure, 2014
- The Th17/Treg imbalance in patients with cardiogenic shockClinical Research in Cardiology, 2013
- Acute myocardial infarction and cardiogenic shockMedizinische Klinik - Intensivmedizin und Notfallmedizin, 2012
- Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic ShockJAMA, 2007
- Systemic Inflammatory Response Syndrome After Acute Myocardial Infarction Complicated by Cardiogenic ShockArchives of internal medicine (1960), 2005
- Soluble CD14 acts as a negative regulator of human T cell activation and functionEuropean Journal of Immunology, 1999